Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004610 (
bacteremia
)
13,199
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Staphylococcus aureus is a major human pathogen causing cutaneous infections to life-threatening
bacteremia
. These infections are often caused by strains derived from the own microflora suggesting that a disturbed epidermal barrier may promote invasion of S. aureus. Antimicrobial peptides and proteins (AMP) such as human beta-defensin-3 and
RNase 7
contribute to control the colonization of S. aureus on the skin surface. This leads to the hypothesis that strains with a decreased susceptibility toward skin-derived AMP may better overcome the innate cutaneous defence barrier increasing the possibility of invading into the blood stream. To address this hypothesis we determined whether S. aureus strains from
bacteremia
patients are less susceptible to various skin-derived AMP than strains from healthy carriers. No differences in the AMP-killing activity against
bacteremia
-derived S. aureus and control strains were detected suggesting that the onset of S. aureus
bacteremia
is not based on the varying susceptibilities against skin-derived AMP.
...
PMID:Susceptibility of Staphylococcus aureus bacteremia strains to different skin-derived antimicrobial proteins. 2295 75